Clinical Trials

IRX Therapeutics asserted that Phase 2 double-blind, randomized, placebo-controlled clinical trial of IRX-2 in women has commenced with squamous cervical intraepithelial neoplasia 3…
Read More...

Mallinckrodt plc  confirmed the enrollment of first patient for the company's Phase 1 study evaluating the safety and tolerance of ExpressGraft C9T1 skin tissue in the treatment of…
Read More...

Precision medicine biotechnology company, developing targeted oncology therapeutics, Trovagene asserted the addition of two leading  institutions,Yale Cancer Center and principal…
Read More...

Astro's Interpretation of the Phase II CONDOR trial suggests that the immune checkpoint inhibitor durvalumab is tolerable among heavily pre-treated patients with recurrent or metastatic…
Read More...

Astro indicates positive results of  phase II OPTIMA Clinical Trial signifying that patients with head and neck cancers associated with the human papillomavirus (HPV), including those…
Read More...

Degenerative disc disease has long been considered an inseparable part of aging but new breakthrough research from SpinalCyte suggests a new cell-based therapy could provide a cure for…
Read More...

DNAnexus announced the availability of its Clinical Trial Solution (CTS) which streamlines the use of next-generation sequencing (NGS) data in regulated clinical trials. The company…
Read More...

Applied Therapeutics announced initiation of a Phase 1 clinical trial for AT-001, an oral small molecule in development for diabetic complications. The Phase 1 clinical trial is a…
Read More...

ERT announced advanced respiratory clinical trial services that centrally collect lung function data using the Forced Oscillation Technique (FOT). This solution is available immediately…
Read More...

Bavarian Nordic A/S announced positive results from a Phase 3 pivotal study of its investigational, non-replicating smallpox vaccine, IMVAMUNE. The study achieved both of its primary…
Read More...

PharmaJet announced that Vaccibody AS is expanding their human clinical trial (phase IIa) for the study of a vaccine to treat HPV disease using the PharmaJet Stratis needle-free…
Read More...

Acesion Pharma announces that it has received approval to commence its first clinical study for its lead compound AP30663. The phase 1 study in healthy subjects will be conducted at the…
Read More...

Sosei Group Corporation announces that its immuno-oncology collaboration with AstraZeneca is progressing well. The first patient has been dosed in an expansion cohort in the Phase 1b…
Read More...

Xcovery announced the initiation of its Phase 2 clinical trial of ensartinib (X-396), the company’s lead anaplastic lymphoma kinase (ALK) drug candidate, in patients with advanced…
Read More...

ORICULA THERAPEUTICS, LLC., a biotech company introducing medications to preserve hearing and balance, announced FDA permission to begin volunteer human testing for safety,…
Read More...

Shield Therapeutics plc announces top-line results from its AEGIS-CKD pivotal Phase III study of Feraccru. Feraccru is a novel oral ferric iron therapy that has been approved and…
Read More...

Clinical-stage pharmaceutical company, Imago BioSciences developing novel therapies for hematological and inflammatory diseases asserted FDA's acceptance of their Investigational New…
Read More...

With a view to permit cancer patients access to potentially life-saving treatments, Lazarex Cancer Foundation's push for FDA issuing new FDA guidelines was taken into account by the…
Read More...

Panacea Pharmaceuticals, a clinical stage bio-pharmaceutical company developing novel biologically--targeted cancer therapies and diagnostics declared the enrollment of patient in an…
Read More...

It is noteworthy that TVA Medical's everlinQ endoAVF System exhibited positive Clinical results using the everlinQ endoAVF System. An international meta-analysis of clinical experience…
Read More...